PharmaResearch Co., Ltd. (KOSDAQ:214450)

Market Cap	6.91T
Revenue (ttm)	392.31B
Net Income (ttm)	110.97B
Shares Out	10.39M
EPS (ttm)	10,648.93
PE Ratio	62.45
Forward PE	33.45
Dividend	1,100.00 (0.16%)
Ex-Dividend Date	Dec 27, 2024

Volume	105,173
Average Volume	91,949
Open	671,000
Previous Close	665,000
Day's Range	670,000 - 694,000
52-Week Range	165,300 - 698,000
Beta	0.60
RSI	69.35
Earnings Date	Aug 12, 2025

About PharmaResearch

PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly patients; PLACENTEX injection for the treatment and tissue restoration of wounds; CLEVIEL VOLUME to temporarily improve facial wrinkles in adults thro...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1993
• Employees: 409
• Stock Exchange: KOSDAQ
• Ticker Symbol: 214450

Financial Performance

In 2024, PharmaResearch's revenue was 350.12 billion, an increase of 34.14% compared to the previous year's 261.01 billion. Earnings were 92.04 billion, an increase of 20.24%.